Potential prospects for use in pathology and treatment include elevated levels of vascular cell adhesion molecule 1 (VCAM-1) and neprilysin in patients with baseline diabetic nephropathy and diabetic nephropathy-treated patients with persisting albuminuria, respectively [106]. This evidence concerns the gene VCAM1 and diabetic kidney disease.